Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections.

Todd DA, Parlet CP, Crosby HA, Malone CL, Heilmann KP, Horswill AR, Cech NB.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00263-17. doi: 10.1128/AAC.00263-17. Print 2017 Aug.

2.

Wearing ID Badges in the Operating Room Environment: Is Reconsideration Warranted?

Hogue MH, Heilmann KP, Callaghan JJ.

J Arthroplasty. 2017 Jul;32(7):2231-2233. doi: 10.1016/j.arth.2017.01.046. Epub 2017 Feb 3.

PMID:
28410834
3.

Correction: Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance.

Quave CL, Lyles JT, Kavanaugh JS, Nelson K, Parlet CP, Crosby HA, Heilmann KP, Horswill AR.

PLoS One. 2016 Sep 22;11(9):e0163655. doi: 10.1371/journal.pone.0163655. eCollection 2016.

4.

Airway acidification initiates host defense abnormalities in cystic fibrosis mice.

Shah VS, Meyerholz DK, Tang XX, Reznikov L, Abou Alaiwa M, Ernst SE, Karp PH, Wohlford-Lenane CL, Heilmann KP, Leidinger MR, Allen PD, Zabner J, McCray PB Jr, Ostedgaard LS, Stoltz DA, Randak CO, Welsh MJ.

Science. 2016 Jan 29;351(6272):503-7. doi: 10.1126/science.aad5589.

5.

Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013.

Richter SS, Doern GV, Heilmann KP, Miner S, Tendolkar S, Riahi F, Diekema DJ.

J Clin Microbiol. 2016 Mar;54(3):812-4. doi: 10.1128/JCM.03109-15. Epub 2016 Jan 13.

6.

Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance.

Quave CL, Lyles JT, Kavanaugh JS, Nelson K, Parlet CP, Crosby HA, Heilmann KP, Horswill AR.

PLoS One. 2015 Aug 21;10(8):e0136486. doi: 10.1371/journal.pone.0136486. eCollection 2015. Erratum in: PLoS One. 2016;11(9):e0163655.

7.

Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Doern GV.

Antimicrob Agents Chemother. 2014 Nov;58(11):6484-9. doi: 10.1128/AAC.03344-14. Epub 2014 Aug 18.

8.

Cultures of diabetic foot ulcers without clinical signs of infection do not predict outcomes.

Gardner SE, Haleem A, Jao YL, Hillis SL, Femino JE, Phisitkul P, Heilmann KP, Lehman SM, Franciscus CL.

Diabetes Care. 2014 Oct;37(10):2693-701. doi: 10.2337/dc14-0051. Epub 2014 Jul 10.

9.

Concordance of nasal and diabetic foot ulcer staphylococcal colonization.

Haleem A, Schultz JS, Heilmann KP, Dohrn CL, Diekema DJ, Gardner SE.

Diagn Microbiol Infect Dis. 2014 May;79(1):85-9. doi: 10.1016/j.diagmicrobio.2014.01.014. Epub 2014 Jan 24.

10.

Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study.

Diekema DJ, Richter SS, Heilmann KP, Dohrn CL, Riahi F, Tendolkar S, McDanel JS, Doern GV.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):285-92. doi: 10.1086/675283. Epub 2014 Jan 29.

PMID:
24521595
11.

Activities of vancomycin, ceftaroline, and mupirocin against Staphylococcus aureus isolates collected in a 2011 national surveillance study in the United States.

Richter SS, Diekema DJ, Heilmann KP, Dohrn CL, Crispell EK, Riahi F, McDanel JS, Satola SW, Doern GV.

Antimicrob Agents Chemother. 2014;58(2):740-5. doi: 10.1128/AAC.01915-13. Epub 2013 Nov 18.

12.

Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

J Clin Microbiol. 2013 Dec;51(12):4193-5. doi: 10.1128/JCM.01876-13. Epub 2013 Sep 11.

13.

Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV.

Emerg Infect Dis. 2013 Jul;19(7):1074-83. doi: 10.3201/eid1907.121830.

14.

In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.

Doern GV, Diekema DJ, Heilmann KP, Dohrn CL, Riahi F, Richter SS.

Antimicrob Agents Chemother. 2012 Jun;56(6):3406-8. doi: 10.1128/AAC.00582-12. Epub 2012 Apr 9.

15.

Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.

Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.

J Clin Microbiol. 2011 Dec;49(12):4203-7. doi: 10.1128/JCM.01152-11. Epub 2011 Oct 5.

16.

Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV.

Antimicrob Agents Chemother. 2011 Sep;55(9):4154-60. doi: 10.1128/AAC.00315-11. Epub 2011 Jun 27.

17.

Collaborative evaluation of an erythromycin-clindamycin combination well for detection of inducible clindamycin resistance in beta-hemolytic streptococci by use of the CLSI broth microdilution method.

Jorgensen JH, McElmeel ML, Fulcher LC, McGee L, Richter SS, Heilmann KP, Ferraro MJ, Spargo J, Glennen A.

J Clin Microbiol. 2011 Aug;49(8):2884-6. doi: 10.1128/JCM.00912-11. Epub 2011 Jun 22.

18.

BD Phoenix and Vitek 2 detection of mecA-mediated resistance in Staphylococcus aureus with cefoxitin.

Junkins AD, Lockhart SR, Heilmann KP, Dohrn CL, Von Stein DL, Winokur PL, Doern GV, Richter SS.

J Clin Microbiol. 2009 Sep;47(9):2879-82. doi: 10.1128/JCM.01109-09. Epub 2009 Jul 22.

19.

Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.

Clin Infect Dis. 2009 Feb 1;48(3):e23-33. doi: 10.1086/595857.

PMID:
19115971
20.

Accuracy of phenotypic methods for identification of Streptococcus pneumoniae isolates included in surveillance programs.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.

J Clin Microbiol. 2008 Jul;46(7):2184-8. doi: 10.1128/JCM.00461-08. Epub 2008 May 21.

21.

Increasing telithromycin resistance among Streptococcus pyogenes in Europe.

Richter SS, Heilmann KP, Dohrn CL, Beekmann SE, Riahi F, Garcia-de-Lomas J, Ferech M, Goossens H, Doern GV.

J Antimicrob Chemother. 2008 Mar;61(3):603-11. doi: 10.1093/jac/dkm525. Epub 2008 Jan 24.

PMID:
18218647
22.

Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae.

Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Ferech M, Goosens H, Doern GV.

Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):485-90.

PMID:
17551759
23.

Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study.

Beekmann SE, Diekema DJ, Heilmann KP, Richter SS, Doern GV.

Eur J Clin Microbiol Infect Dis. 2006 May;25(5):335-9.

PMID:
16612609
24.

Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.

Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV.

Clin Infect Dis. 2005 Sep 1;41(5):599-608.

PMID:
16080080
25.

Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.

Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, Richter SS, Doern GV.

Antimicrob Agents Chemother. 2005 Jun;49(6):2561-4.

26.
27.

The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.

Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Rice CL, Doern GV.

Clin Infect Dis. 2005 Jan 15;40(2):225-35. Epub 2004 Dec 21.

PMID:
15655739
28.

The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species.

Richter SS, Kealey DE, Murray CT, Heilmann KP, Coffman SL, Doern GV.

J Antimicrob Chemother. 2003 Jul;52(1):123-7. Epub 2003 Jun 12.

PMID:
12805265
29.

Fluoroquinolone resistance in Streptococcus pyogenes.

Richter SS, Diekema DJ, Heilmann KP, Almer LS, Shortridge VD, Zeitler R, Flamm RK, Doern GV.

Clin Infect Dis. 2003 Feb 1;36(3):380-3. Epub 2003 Jan 14.

PMID:
12539083
30.

The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.

Richter SS, Heilmann KP, Coffman SL, Huynh HK, Brueggemann AB, Pfaller MA, Doern GV.

Clin Infect Dis. 2002 Feb 1;34(3):330-9. Epub 2001 Dec 17.

PMID:
11774080
31.

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB.

Antimicrob Agents Chemother. 2001 Jun;45(6):1721-9.

Supplemental Content

Loading ...
Support Center